This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Massachusetts Institute of Technology. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Jonathan Wilde in Chromosomal Recombination
Introduction
Jonathan Wilde is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of genetic engineering, particularly in enhancing chromosomal homologous recombination. His innovative methods have the potential to revolutionize approaches to gene therapy and disease prevention.
Latest Patents
Wilde holds a patent for "Methods of enhancing chromosomal homologous recombination." This patent describes methods that stimulate a loss of heterozygosity at a gene locus of interest in living cells. The techniques involve an enhancer component and a target-specific endonuclease component. Notably, these methods do not require the introduction of exogenous donor DNA into the living cell. The desired allele remains uncleaved, while the undesired allele can be cleaved at one or multiple locations. The applications of these methods are vast, including the repair of risk alleles for disease prevention, correction of heterozygous mutations in dividing cells, and the design of cancer therapeutics.
Career Highlights
Jonathan Wilde is affiliated with the Massachusetts Institute of Technology, where he conducts research and develops innovative solutions in genetic engineering. His work has garnered attention for its potential impact on medical science and biotechnology.
Collaborations
Wilde collaborates with notable researchers such as Guoping Feng and Tomomi Aida, contributing to advancements in their shared field of study.
Conclusion
Jonathan Wilde's innovative methods in enhancing chromosomal homologous recombination represent a significant advancement in genetic engineering. His contributions have the potential to lead to breakthroughs in disease prevention and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
